Role of potassium-competitive acid blockers in eradication of Helicobacter pylori infection

被引：1
作者：
Kim, Tae Ho [1 ,2 ]
机构：
[1] Catholic Univ Korea, Bucheon St, Bucheon, South Korea
[2] Bucheon St, 327 Sosa-ro, Bucheon, South Korea
来源：
KOREAN JOURNAL OF INTERNAL MEDICINE | 2023年 / 38卷 / 04期
关键词：
TRIPLE THERAPY; VONOPRAZAN; 1ST-LINE;
D O I：
10.3904/kjim.2023.250
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：451 / 453
页数：3
相关论文
共 10 条
[1]   Pharmacokinetics and Pharmacodynamics of Tegoprazan Coadministered With Amoxicillin and Clarithromycin in Healthy Subjects [J].
Ghim, Jong-Lyul ;
Chin, May Chien ;
Jung, Jinah ;
Lee, Jiwon ;
Kim, Seokuee ;
Kim, Bongtae ;
Song, Geun Seog ;
Choi, Young-Kyung ;
Shin, Jae-Gook .
JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (07) :913-922
[2]   Safety profile of vonoprazan compared with proton pump inhibitors: insight from a pharmacovigilance study [J].
Kambara, H. ;
Hosohata, K. ;
Nakatsuji, T. ;
Ueno, S. ;
Oyama, S. ;
Inada, A. ;
Niinomi, I ;
Wakabayashi, T. ;
Iwanaga, K. .
PHARMAZIE, 2020, 75 (10) :527-530
[3]   Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea [J].
Kim, Beom Jin ;
Lee, Hyuk ;
Lee, Yong Chan ;
Jeon, Seong Woo ;
Kim, Gwang Ha ;
Kim, Hyun-Soo ;
Sung, Jae Kyu ;
Lee, Dong Ho ;
Kim, Heung Up ;
Park, Moo In ;
Choi, Il Ju ;
Yoon, Soon Man ;
Kim, Sang Wook ;
Baik, Gwang Ho ;
Lee, Ju Yup ;
Kim, Jin Il ;
Kim, Sang Gyun ;
Kim, Jayoun ;
Lee, Joongyup ;
Kim, Jae Gyu ;
Kim, Jae J. .
GUT AND LIVER, 2019, 13 (05) :531-540
[4]   Comparison of 7-and 14-Day Eradication Therapy for Helicobacter pylori with First- and Second-Line Regimen: Randomized Clinical Trial [J].
Kim, Tae Ho ;
Park, Jae Myung ;
Cheung, Dae Young ;
Oh, Jung Hwan .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (05)
[5]  
Kim TH, 2018, KOREAN J HELICOBACTE, V18, P79
[6]   Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report [J].
Malfertheiner, Peter ;
Megraud, Francis ;
Rokkas, Theodore ;
Gisbert, Javier P. ;
Liou, Jyh-Ming ;
Schulz, Christian ;
Gasbarrini, Antonio ;
Hunt, Richard H. ;
Leja, Marcis ;
O'Morain, Colm ;
Rugge, Massimo ;
Suerbaum, Sebastian ;
Tilg, Herbert ;
Sugano, Kentaro ;
El-Omar, Emad M. .
GUT, 2022, 71 (09) :1724-1762
[7]   Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study [J].
Murakami, Kazunari ;
Sakurai, Yuuichi ;
Shiino, Madoka ;
Funao, Nobuo ;
Nishimura, Akira ;
Asaka, Masahiro .
GUT, 2016, 65 (09) :1439-1446
[8]   A comparison of efficacy and safety of potassium-competitive acid blocker and proton pump inhibitor in gastric acid-related diseases: A systematic review and meta-analysis [J].
Simadibrata, Daniel Martin ;
Syam, Ari Fahrial ;
Lee, Yeong Yeh .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (12) :2217-2228
[9]   Kyoto global consensus report on Helicobacter pylori gastritis [J].
Sugano, Kentaro ;
Tack, Jan ;
Kuipers, Ernst J. ;
Graham, David Y. ;
El-Omar, Emad M. ;
Miura, Soichiro ;
Haruma, Ken ;
Asaka, Masahiro ;
Uemura, Naomi ;
Malfertheiner, Peter .
GUT, 2015, 64 (09) :1353-1367
[10]   Efficacy and safety of potassium-competitive acid blockers versus proton pump inhibitors as Helicobacter pylori eradication therapy: a meta-analysis of randomized clinical trials [J].
Zhang, Mengran ;
Pang, Mingge ;
Zhang, Mei .
CLINICS, 2022, 77
1